ArticleProceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences2026
What Are You Craving? Using Wearables to Distinguish Food and Drug Cravings During Treatment with Extended-Release Buprenorphine.
Article in Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Craving, or the subjective, strong desire to use a substance, is a central factor in addiction, and part of the diagnostic criteria for substance use disorders (SUDs). Cravings can also occur for other triggers such as food, and cravings for food and drugs have been found to activate distinct neural pathways in the brain. Recently, physiologic signals from wearable devices have been applied to digitally detect cravings in patients with SUDs. But to date, no studies have explored digital detection of cravings by subtype. We collected continuous physiologic sensor data from N = 12 participants with opioid use disorder (OUD), treated with extended-release buprenorphine (BUP-XR). Data were analyzed to assess whether sensor signals carried differential information that could distinguish between food-, drug- and mixed-craving types. Accelerometer, heart rate and heart rate variability features significantly differed between drug, food and mixed trigger cravings. Cross validated models trained with these features distinguished each type of craving with area under ROC curve ranging from 75%-80%. These findings support the ability of wearable sensor-based digital biomarkers to distinguish craving subtypes in individuals with OUD.
Indexed as
Identifiers
41602282PMC12834459What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.